NYSE:ADNT - Adient Stock Price, Forecast & News

Adient's stock was trading at $16.45 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ADNT shares have decreased by 44.3% and is now trading at $9.17. View which stocks have been mosted impacted by Coronavirus.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Adient in the last year. There are currently 9 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Adient.

Adient is scheduled to release its next quarterly earnings announcement on Tuesday, May 5th 2020. View our earnings forecast for Adient.

Adient PLC (NYSE:ADNT) posted its earnings results on Friday, January, 31st. The company reported $0.96 EPS for the quarter, topping analysts' consensus estimates of $0.31 by $0.65. The firm had revenue of $3.94 billion for the quarter, compared to analysts' expectations of $3.82 billion. Adient had a positive return on equity of 9.32% and a negative net margin of 3.93%. The company's quarterly revenue was down 5.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.31 EPS. View Adient's earnings history.

Adient issued an update on its FY 2020 Pre-Market earnings guidance on Friday, January, 31st. The company provided EPS guidance of for the period. The company issued revenue guidance of $15.6-15.8 billion, compared to the consensus revenue estimate of $15.73 billion.

12 brokerages have issued twelve-month target prices for Adient's stock. Their forecasts range from $12.00 to $30.00. On average, they anticipate Adient's share price to reach $24.11 in the next year. This suggests a possible upside of 162.9% from the stock's current price. View analysts' price targets for Adient.

Media headlines about ADNT stock have been trending somewhat negative on Saturday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Adient earned a coverage optimism score of -1.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutAdient.

Adient saw a increase in short interest in March. As of March 13th, there was short interest totaling 5,971,800 shares, an increase of 26.5% from the February 27th total of 4,720,000 shares. Based on an average daily trading volume, of 1,490,000 shares, the short-interest ratio is currently 4.0 days. Currently, 6.4% of the shares of the stock are short sold. View Adient's Current Options Chain.

Some companies that are related to Adient include Autoliv (ALV), Allison Transmission (ALSN), LCI Industries (LCII), Dorman Products (DORM), Dana (DAN), Meritor (MTOR), Gentherm (THRM), Delphi Technologies (DLPH), Standard Motor Products (SMP), Veoneer (VNE), Tower International (TOWR), American Axle & Manufact. (AXL), Stoneridge (SRI), IOCHPE MAXION S/S (IOCJY) and Garrett Motion (GTX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Adient investors own include Johnson Controls International (JCI), AT&T (T), Exxon Mobil (XOM), AbbVie (ABBV), Cisco Systems (CSCO), Pfizer (PFE), Verizon Communications (VZ), Ford Motor (F), Gilead Sciences (GILD) and Bristol-Myers Squibb (BMY).

Adient trades on the New York Stock Exchange (NYSE) under the ticker symbol "ADNT."

Adient's stock is owned by many different retail and institutional investors. Top institutional investors include Hotchkis & Wiley Capital Management LLC (8.72%), Lyrical Asset Management LP (5.45%), State Street Corp (3.10%), Letko Brosseau & Associates Inc. (3.05%), Barrow Hanley Mewhinney & Strauss LLC (2.98%) and Investec Asset Management LTD (2.66%). Company insiders that own Adient stock include Gregory Scott Smith, Jeffrey Stafeil and Jerome J Dorlack. View institutional ownership trends for Adient.

ADNT stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Bank of America Corp DE, Letko Brosseau & Associates Inc., Cubist Systematic Strategies LLC, Credit Suisse AG, Cipher Capital LP, Geode Capital Management LLC, and Connor Clark & Lunn Investment Management Ltd.. View insider buying and selling activity for Adient.

ADNT stock was bought by a variety of institutional investors in the last quarter, including Investec Asset Management LTD, Norges Bank, Prudential Financial Inc., Hotchkis & Wiley Capital Management LLC, Barrow Hanley Mewhinney & Strauss LLC, Marshall Wace LLP, Lyrical Asset Management LP, and Nuveen Asset Management LLC. Company insiders that have bought Adient stock in the last two years include Gregory Scott Smith, Jeffrey Stafeil, and Jerome J Dorlack. View insider buying and selling activity for Adient.

Shares of ADNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ADNT stock can currently be purchased for approximately $9.17.

Adient has a market capitalization of $860.05 million and generates $16.53 billion in revenue each year. The company earns $-491,000,000.00 in net income (profit) each year or $1.63 on an earnings per share basis. Adient employs 83,000 workers across the globe. View additional information about Adient.

The official website for Adient is http://www.adient.com/.

Adient's mailing address is 49200 Halyard Drive, Plymouth MI, 48170. The company can be reached via phone at 734-254-5000.